Sarinex (desloratadine ) is a long-acting tricyclic major active metabolite of the parent drug
loratadine with selective H1 –receptor antagonist activity.

INDICATIONS
It is indicated for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (SAR),
perennial allergic rhinitis (PAR) . It is also indicated for the symptomatic relief of pruritus, reduction in the number of hives, size of hives and in patients with chronic idiopathic urticaria.

DOSAGE AND ADMINISTRATION
As there are no food effects on the bioavailability, Sarinex may be taken without regard to meal.
Adults and adolescent of 12 years or over : 5 mg once daily.
Patients with liver or renal impairment : a starting dose of every other day is recommended.

PREGNANCY AND LACTATION
Sarinex is in the Pregnancy Category C. It passes into breast milk; therefore a decision should be made whether to discontinue nursing or to discontinue desloratadine, taking into account the
importance of the drug to the mother.

 PACKAGING
Sarinex tablet: Each box contains 5 x 10’s tablet in blister pack. Each film-coated tablet contains desloratadine INN 5mg.

Manufactured by
Delta Pharma Limited,Bangladesh